Chronic Inflammatory Demyelinating Polyneuropathy Associated with Active Systemic Lupus Erythematous: Anifrolumab as a Potentially Successful Add-On Therapy to Intravenous Immunoglobulins
AuthID
P-017-Z2H
P-017-Z2H